News

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.
President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.
Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.
European countries are not all equally exposed to the US market and so will not suffer the same consequences should President ...